SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12860578
Source:
http://linkedlifedata.com/resource/pubmed/id/12860578
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0005823
,
umls-concept:C0011881
,
umls-concept:C0441889
,
umls-concept:C0449258
,
umls-concept:C1274040
,
umls-concept:C1280500
,
umls-concept:C2603343
pubmed:issue
13
pubmed:dateCreated
2003-7-15
pubmed:abstractText
Clinical trials of nephropathy in people with type 2 diabetes mellitus have not examined the effects of systolic blood pressure (SBP) or pulse pressure (PP) on the time to end-stage renal disease (ESRD) or death.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12860578-14744850
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372440
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers
,
http://linkedlifedata.com/resource/pubmed/chemical/Losartan
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0003-9926
pubmed:author
pubmed-author:BakrisGeorge LGL
,
pubmed-author:BrennerBarry MBM
,
pubmed-author:DouglasJaniceJ
,
pubmed-author:RENAAL Study Group
,
pubmed-author:ShanifarShahnazS
,
pubmed-author:WeirMatthew RMR
,
pubmed-author:ZhangZhongxinZ
,
pubmed-author:van DijkDavid JDJ
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
163
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1555-65
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:12860578-Antihypertensive Agents
,
pubmed-meshheading:12860578-Calcium Channel Blockers
,
pubmed-meshheading:12860578-Diabetes Mellitus, Type 2
,
pubmed-meshheading:12860578-Diabetic Nephropathies
,
pubmed-meshheading:12860578-Disease Progression
,
pubmed-meshheading:12860578-Double-Blind Method
,
pubmed-meshheading:12860578-Female
,
pubmed-meshheading:12860578-Humans
,
pubmed-meshheading:12860578-Hypertension
,
pubmed-meshheading:12860578-Kidney Failure, Chronic
,
pubmed-meshheading:12860578-Losartan
,
pubmed-meshheading:12860578-Male
,
pubmed-meshheading:12860578-Middle Aged
,
pubmed-meshheading:12860578-Proportional Hazards Models
,
pubmed-meshheading:12860578-Risk Factors
pubmed:year
2003
pubmed:articleTitle
Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
pubmed:affiliation
Department of Preventive Medicine, Rush Presbyterian/St Luke's Medical Center, Rush Medical College, Chicago, IL 60612, USA. gbakris@earthlink.net
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Multicenter Study